252 related articles for article (PubMed ID: 36240167)
21. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
22. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
Pichini S; Mannocchi G; Berretta P; Zaami S; Pirani F; Pacifici R; Busardò FP
Ther Drug Monit; 2020 Feb; 42(1):151-156. PubMed ID: 31389860
[TBL] [Abstract][Full Text] [Related]
23. Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants.
Peters EN; Mosesova I; MacNair L; Vandrey R; Land MH; Ware MA; Turcotte C; Bonn-Miller MO
J Anal Toxicol; 2022 May; 46(5):528-539. PubMed ID: 33848338
[TBL] [Abstract][Full Text] [Related]
24. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.
van de Donk T; Niesters M; Kowal MA; Olofsen E; Dahan A; van Velzen M
Pain; 2019 Apr; 160(4):860-869. PubMed ID: 30585986
[TBL] [Abstract][Full Text] [Related]
25. Nanomaterials-Based Electrochemical Δ
Pazuki D; Ghosh R; Howlader MMR
Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979596
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD
Chicoine A; Illing K; Vuong S; Pinto KR; Alcorn J; Cosford K
Front Vet Sci; 2020; 7():583404. PubMed ID: 33134364
[No Abstract] [Full Text] [Related]
27. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use.
Casati S; Angeli I; Bergamaschi RF; Ravelli A; Colombo G; Binelli G; Minoli M; Orioli M
Forensic Sci Int; 2022 Apr; 333():111237. PubMed ID: 35228140
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.
Bonomo Y; Norman A; Collins L; O'Neill H; Galettis P; Trinca J; Strauss N; Martin J; Castle D
Pain Ther; 2022 Mar; 11(1):171-189. PubMed ID: 34921662
[TBL] [Abstract][Full Text] [Related]
29. Cannabis constituent synergy in a mouse neuropathic pain model.
Casey SL; Atwal N; Vaughan CW
Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
[TBL] [Abstract][Full Text] [Related]
30. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Grimison P; Mersiades A; Kirby A; Lintzeris N; Morton R; Haber P; Olver I; Walsh A; McGregor I; Cheung Y; Tognela A; Hahn C; Briscoe K; Aghmesheh M; Fox P; Abdi E; Clarke S; Della-Fiorentina S; Shannon J; Gedye C; Begbie S; Simes J; Stockler M
Ann Oncol; 2020 Nov; 31(11):1553-1560. PubMed ID: 32801017
[TBL] [Abstract][Full Text] [Related]
31. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
33. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Morini L; Porro G; Liso M; Groppi A
Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
Rodriguez CEB; Ouyang L; Kandasamy R
Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
[TBL] [Abstract][Full Text] [Related]
36. Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms.
Domen CH; Sillau S; Liu Y; Adkins M; Rajkovic S; Bainbridge J; Sempio C; Klawitter J; Leehey MA
Mov Disord; 2023 Jul; 38(7):1341-1346. PubMed ID: 37212386
[TBL] [Abstract][Full Text] [Related]
37. Comment on Lachenmeier
Kruse D; Beitzke B
F1000Res; 2020; 9():900. PubMed ID: 32864108
[TBL] [Abstract][Full Text] [Related]
38. Cannabis-Based Products for Chronic Pain : A Systematic Review.
McDonagh MS; Morasco BJ; Wagner J; Ahmed AY; Fu R; Kansagara D; Chou R
Ann Intern Med; 2022 Aug; 175(8):1143-1153. PubMed ID: 35667066
[TBL] [Abstract][Full Text] [Related]
39. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
